NCT00876083已完成不适用
Post-marketing Surveillance Study Ultravist®-IMAGE IoproMide (UltrAvist®) to Gain Further Information on Tolerability and Safety in X-ray Examination
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Bayer
- 入组人数
- 44,920
- 主要终点
- Occurrence of adverse events
研究概览
简要总结
The purpose of this study is to obtain data on the safety and efficacy of Ultravist application in usual daily use.The radiologist will administer the contrast medium to the patient as he/she would have done without the study. No other examinations will be performed than would have been done routinely.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with indication for an X-ray examination and for whom the radiologist has decided to use the contrast medium Ultravist.
排除标准
- •No exclusion criteria besides the contraindications for the use of Ultravist as mentioned in the product information.
研究组 & 干预措施
Group 1
干预措施: Ultravist (Iopromide, BAY86-4877) (Drug)
结局指标
主要结局
Occurrence of adverse events
时间窗: During and after Ultravist application on the day of examination
次要结局
- General contrast quality in the region of interest as assessed by physicians(On the day of examination)
研究者
相似试验
Unknown
不适用
Feasibility of the Ultravision™ System in Low Pressure Laparoscopic Cholecystectomy Compared to Airseal® IFSLaparoscopic CholecystectomyNCT04162106Alesi Surgical Ltd.60
已完成
不适用
Evaluate the Safety and Effectiveness of Sovaldi in Participants With Chronic Hepatitis C Virus (HCV) Infection in KoreaHepatitis C VirusNCT02907996Gilead Sciences2,033
已完成
不适用
Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®)DiabetesDiabetes Mellitus, Type 2NCT02321878Novo Nordisk A/S1,092
已完成
不适用
Lyrica (Pregabalin) Korean Post Marketing Surveillance StudyNeuropathic PainPost-market SurveillanceEpilepsyFibromyalgiaNCT01220180Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4,175
已完成
不适用
A Study for PMS of AZL-M/CLD FDC in the Treatment of Participants With Essential HTN in South KoreaEssential HypertensionNCT04470830Celltrion Pharm, Inc.718